Find and assess assets on complete, source-traceable trial evidence

The full evidence behind a target, traceable enough to defend a licensing call.

The job, and where current tools fall short

Business development and search and evaluation teams weigh the cost and access of the gold-standard tools against the risk of trusting AI output on a licensing decision. You need the whole evidence base and a trail you can show a diligence committee.

What TrialForge gives you

  • Asset-to-trial and lines-of-therapy mapping across the landscape.
  • The full evidence behind a target, with every field traceable to its source.
  • Traceability to defend the diligence, not just inform it.
  • Specialist depth in China.

Assess your next asset in TrialForge

See how teams across biopharma defend their next pipeline call with TrialForge

Book a demo